Sclerotherapy Market Size To Reach $1.50 Billion By 2030

Sclerotherapy Market Growth & Trends

The global sclerotherapy market size is estimated to reach USD 1.50 billion by 2030, expanding at a CAGR of 4.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. Sclerotherapy is a non-invasive procedure that is widely used as a primary treatment for reticular veins, leg telangiectasias, and varicose veins. The procedure comprises injecting a solution (sclerosing agents or sclerosants) straight into the affected veins, which causes them to shrink and eventually disappear and assist in treating related symptoms such as aching, burning, swelling, and cramping. Factors like the better exposure to the site of application, utilization of less-invasive technologies, advances in dermatology, and increasing geriatric population with an incidence of varicose veins are fuelling the market growth.

Sclerosing agents used for the treatment of varicose veins are segmented into detergents, hyperosmolar/ osmotic agents, and chemical irritants. Agents like Sodium tetradecyl sulfate (Sotradecol) and Polidocanol (Asclera), Sodium morrhuate (Scleromate), Ethanolamine Oleate (Ethamoline) are all FDA approved sclerosants used to treat and reduce the effect of vein damage. According to the Society of Vascular surgery, more than 33.0% of women and about 17.0% of men consult a doctor for telangiectasias and varicose veins in industrialized countries, affecting up to 35.0% of people in the U.S. alone.

This condition, if left untreated can cause severe health problems such as chronic pain, deep vein clots, skin ulcers, and coronary ailments. According to NCBI, 20.0% of all adults will get varicose veins at some point in their lives and the prevalence is higher among the aging population and women. These factors are expected to boost the market growth. However, the side effects of this procedure such as hyperpigmentation and matting, scarring, and allergic reactions in some patients might hinder the market growth.

 Request a free sample copy or view report summary: Sclerotherapy Market Report

Sclerotherapy Market Report Highlights

• The detergents segment dominated the market with a revenue share of 43.5% in 2024 owing to high approvals by the FDA, low risk of clot formation, effectiveness, and its popularity among doctors

• The foam sclerotherapy segment is anticipated to grow fast over the forecast period due to better exposure to the onsite and results than liquid sclerotherapy

• North America sclerotherapy market dominated the global with a revenue share of 44.5% in 2024 owing to increasing demand for new technologies, a large pool of key players, rising prevalence of varicose veins, and advanced healthcare infrastructure in the region

• Asia Pacific sclerotherapy market is expected to register the highest CAGR of 5.7% over the forecast period

Sclerotherapy Market Segmentation

Grand View Research has segmented the global sclerotherapy market based on agents, type, application, and region:

Sclerotherapy Agents Outlook (Revenue, USD Billion, 2018 - 2030)

• Detergents

• Chemical Irritants

• Osmotic Agents

Sclerotherapy Type Outlook (Revenue, USD Billion, 2018 - 2030)

• Ultrasound Sclerotherapy

• Liquid Sclerotherapy

• Foam Sclerotherapy

Sclerotherapy Application Outlook (Revenue, USD Billion, 2018 - 2030)

• Varicose Veins

• Malformed Lymph Vessels

• Hemorrhoids

• Hydroceles

Sclerotherapy Regional Outlook (Revenue, USD Billion, 2018 - 2030)

• North America

  • U.S.    

  • Canada

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Norway

  • Denmark

  • Sweden

• Asia Pacific

  • Japan

  • China

  • India

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Mexico

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in Sclerotherapy Market

• LGM Pharma

• Troikaa

• Viatris Inc.

• Omega Pharmaceuticals Pvt. Ltd.

• Merz Pharma

• ENDO-FLEX GmbH.

• Perrigo Company plc

• Medi-Globe GmbH.

• Medtronic

• AngioDynamics